Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae
about
Cloning and characterization of the gene coding for NADPH-sulfite reductase hemoprotein from Actinobacillus pleuropneumoniae and use of the protein product as a vaccine.Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.A novel Respiratory Health Score (RHS) supports a role of acute lung damage and pig breed in the course of an Actinobacillus pleuropneumoniae infectionSafety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1Effect of iron restriction on the outer membrane proteins of Actinobacillus (Haemophilus) pleuropneumoniae.A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responsesImmune response to an Actinobacillus pleuropneumoniae vaccine in swineTemperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in miceType IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia.Use of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in a miniature pig (Sus scrofa domestica) with pneumonia.Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine developmentInhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.Immunogenicity of Actinobacillus pleuropneumoniae outer membrane proteins and enhancement of phagocytosis by antibodies to the proteins.Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infectionTransposon mutagenesis in Actinobacillus pleuropneumoniae with a Tn10 derivative.Effects of Actinobacillus pleuropneumoniae hemolysin on porcine neutrophil function.Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.Characterization of two genes encoding distinct transferrin-binding proteins in different Actinobacillus pleuropneumoniae isolates.Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5.Analysis of major antigens of Haemophilus (Actinobacillus) pleuropneumoniae and related organisms.Efficacy of an Actinobacillus pleuropneumoniae bacterin against serotypes 1, 3, 5 and 9Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae.A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model.Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs.
P2860
Q28344232-D0FF93CA-BD36-4999-B702-7D2D2711D51FQ33411995-FC78AC2A-A2CA-47F4-97FA-55D7216852B2Q33433182-0381F02E-F3CA-41CC-9D91-E8DD4EC39F1DQ33594737-C51659E4-3D0B-406D-ABF4-90E737F316B1Q34000968-E61C4FA0-38C8-45CD-AE85-79FF20E765E3Q34523958-7DAB98A5-BD22-4C37-9B19-CDFE3C03B8E0Q35092332-5EF0660E-8C6E-4245-8935-F2386ADDE175Q35095758-4BBE0A15-2421-4B2C-B693-A71D6299B6F4Q35192979-AF3FE5ED-177E-472F-A45E-C96A34B3E7A1Q35549028-5579D2E5-37FF-4261-B246-DAF8F2695F84Q35747681-349C577D-03BB-481C-999D-1AA55BA1BFD9Q36000030-55766ED8-7516-4986-86B3-D57BC912F483Q36606746-408920C1-1C85-4D2F-832E-3E91A163AD37Q36950874-0E18CA6B-2DAF-4C13-B310-A967CE4201BFQ36961132-0FCC2664-59D2-444E-AAF3-2AB20DD29BADQ36976522-DF9C5745-5EE6-46F0-906E-C6BCB6DD2F1DQ37013973-AAD73795-9022-4259-9BB1-E4C7B9FBEB10Q39936812-124376BE-46BE-4A34-A3E8-5410848576E7Q40146270-A9851485-A25F-47ED-A7A2-C44699339A36Q40147427-E3427142-059B-4832-9547-2A3AF3628111Q40147572-471C2D0E-2949-42CB-AD7A-77D83D7E26FEQ40149227-8C259877-B867-483C-990F-8DB3A158254EQ40158407-A634D005-45B1-4546-A3C5-0840BCFD62A0Q40163593-263C2338-634E-4364-82A4-74962EEECB1EQ40676908-A30D2610-6A4D-44EB-B7C5-CDD9D69E44B9Q41475377-DA734AD6-9AC5-4215-B274-8FE0C8EBE63EQ42745711-55A4352F-FA62-43F8-BFBC-4AEBAFF2A2CEQ48158997-B389EA8C-A649-43C2-B58E-E8F09212AC42Q55451513-C710214D-75C0-40D9-A8CA-728F02C9A847
P2860
Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@ast
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@en
type
label
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@ast
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@en
prefLabel
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@ast
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@en
P2093
P2860
P1476
Evaluation of a Killed Vaccine ...... o Haemophilus pleuropneumoniae
@en
P2093
G P Martineau
K R Mittal
P Rousseau
S Larivière
P2860
P577
1985-02-01T00:00:00Z